Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Oral Pathol Med ; 38(7): 580-3, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19473447

RESUMO

BACKGROUND: Actinic cheilitis (AC) is an oral pre-cancerous lesion that sometimes develops into lip squamous cell carcinoma (SCC). Syndecan-1, a transmembrane heparan sulfate proteoglycan, modulates cell-proliferation, adhesion, migration and angiogenesis. Malignant epithelial cells often down-regulate their own syndecan-1 production, and are capable of inducing aberrant syndecan-1 expression in stromal cells. The aim of this study was to evaluate the variations in syndecan-1 expression during lip carcinogenesis, in normal lip (NL), AC and well-differentiated lip SCC. METHODS: Biopsies of NL vermillion (n = 19), AC (n = 23) and lip SCC (n = 24) were stained immunohistochemically for syndecan-1. RESULTS: Syndecan-1 expression was significantly reduced in AC and lip SCC as compared to NL (P < 0.05), with a significant reduction in lip SCC as compared to AC (P < 0.0001). In lip SCC lesions, syndecan-1 expression at the epithelium overlying the tumor was increased when compared to the tumor itself (P < 0.03), but was significantly reduced as compared to AC and NL (P < 0.001). CONCLUSION: The results showed that epithelial syndecan-1 expression is reduced as lip carcinogenesis progresses (NL>AC>lip SCC), suggesting that syndecan-1 could be a useful marker of malignant transformation in the lip.


Assuntos
Carcinoma de Células Escamosas/metabolismo , Queilite/metabolismo , Ceratose Actínica/metabolismo , Neoplasias Labiais/metabolismo , Sindecana-1/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/metabolismo , Carcinoma de Células Escamosas/patologia , Estudos de Casos e Controles , Queilite/complicações , Queilite/patologia , Feminino , Humanos , Ceratose Actínica/complicações , Ceratose Actínica/patologia , Lábio/metabolismo , Lábio/patologia , Neoplasias Labiais/patologia , Masculino , Pessoa de Meia-Idade , Valores de Referência
2.
J Oral Pathol Med ; 34(5): 257-62, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15817067

RESUMO

BACKGROUND: Actinic cheilitis (AC) is a pre-malignant lesion caused by ultraviolet (UV) radiation. The apoptotic proteins p53, bax, bcl-2, and the proliferation marker Ki-67, are known to play an important role in UV-exposed skin and carcinomas, therefore, these markers were assessed in AC and compared with normal lip and oral mucosa. METHODS: AC (n = 13), normal lip (n = 7) and oral mucosa (n = 6) biopsies were stained immunohistochemically for p53, bax, bcl-2 and Ki-67, to determine their expression and distribution. RESULTS: p53 was over-expressed in AC as compared with normal lip and oral mucosa (P < 0.003). Although bcl-2 expression was higher in AC than in oral mucosa (P < 0.002), it was significantly reduced as compared with normal lip (P < 0.04). Bax expression remained unchanged, and Ki-67 was significantly increased in AC and normal lip as compared with oral mucosa (P < 0.05). CONCLUSION: The results suggest that DNA-damaged cells by UV radiation in AC are eliminated by apoptosis.


Assuntos
Apoptose , Queilite/metabolismo , Antígeno Ki-67/biossíntese , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteína Supressora de Tumor p53/biossíntese , Adulto , Idoso , Análise de Variância , Proliferação de Células , Queilite/etiologia , Feminino , Humanos , Lábio/metabolismo , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/metabolismo , Estatísticas não Paramétricas , Raios Ultravioleta/efeitos adversos , Proteína X Associada a bcl-2
3.
Artigo em Inglês | MEDLINE | ID: mdl-11113814

RESUMO

In porphyria cutanea tarda, the most common type of porphyria, blisters of the skin occur because of high sensitivity to sunlight. This case report describes porphyria cutanea tarda of the lower lip mimicking an actinic cheilitis in a 62-year-old man with a history of Hodgkin's lymphoma.


Assuntos
Doenças Labiais/patologia , Porfiria Cutânea Tardia/patologia , Administração Tópica , Anti-Inflamatórios/uso terapêutico , Queilite/diagnóstico , Cloroquina/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Diagnóstico Diferencial , Humanos , Hidrocortisona , Hidroxicloroquina/uso terapêutico , Doenças Labiais/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Porfiria Cutânea Tardia/tratamento farmacológico , Protetores Solares/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...